| 000 | 01334 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512023927.0 | ||
| 264 | 0 | _c19880803 | |
| 008 | 198808s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM198807213190306 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoldman, L | |
| 245 | 0 | 0 |
_aCosts and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cJul 1988 |
||
| 300 |
_a152-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xtherapeutic use |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLife Expectancy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPropranolol _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aSia, S T | |
| 700 | 1 | _aCook, E F | |
| 700 | 1 | _aRutherford, J D | |
| 700 | 1 | _aWeinstein, M C | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 319 _gno. 3 _gp. 152-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM198807213190306 _zAvailable from publisher's website |
| 999 |
_c2904576 _d2904576 |
||